Abstract
Nanosponges are nanosized novel drug delivery systems which are developed by cross linking the polymers with the cross linking agent. The most commonly used polymer is β-cyclodextrin because it is biodegradable and can form nanosponge having crystalline or amorphous porous structure and spherical shape with uniformity. These nanosponges have the ability to encapsulate lipophillic as well as hydrophilic moiety. The release rate of the drug can be modulated by varying the ratio of polymer to cross linking agent. Nanosponges are very minute structures such that they can be used for targeting the drug to the specific site by conjugating the ligands onto their surface. Nanosponges can be employed to enhance the aqueous solubility of poorly water soluble drugs, improve bioavailability, and protect photo sensitive drugs, for sustained release and for site specific drug delivery. Nanosponge technology is also employed in the fields other than pharmacy and medicine like water purification, for pollution free environment, in gas storage and also in agriculture. It is a unique and multifunctional technology, considered to be suitable for the drug delivery.
Keywords: β-cyclodextrin, bioavailability, cross-linking, nanosponge, sustained drug delivery.
Drug Delivery Letters
Title:Nanosponge: A Novel Carrier for Drug Delivery
Volume: 3 Issue: 3
Author(s): Rehana Ansari, Rachna Maheshwari, Shikha Jain, Suresh C. Mahajan and Vikas Jain
Affiliation:
Keywords: β-cyclodextrin, bioavailability, cross-linking, nanosponge, sustained drug delivery.
Abstract: Nanosponges are nanosized novel drug delivery systems which are developed by cross linking the polymers with the cross linking agent. The most commonly used polymer is β-cyclodextrin because it is biodegradable and can form nanosponge having crystalline or amorphous porous structure and spherical shape with uniformity. These nanosponges have the ability to encapsulate lipophillic as well as hydrophilic moiety. The release rate of the drug can be modulated by varying the ratio of polymer to cross linking agent. Nanosponges are very minute structures such that they can be used for targeting the drug to the specific site by conjugating the ligands onto their surface. Nanosponges can be employed to enhance the aqueous solubility of poorly water soluble drugs, improve bioavailability, and protect photo sensitive drugs, for sustained release and for site specific drug delivery. Nanosponge technology is also employed in the fields other than pharmacy and medicine like water purification, for pollution free environment, in gas storage and also in agriculture. It is a unique and multifunctional technology, considered to be suitable for the drug delivery.
Export Options
About this article
Cite this article as:
Ansari Rehana, Maheshwari Rachna, Jain Shikha, C. Mahajan Suresh and Jain Vikas, Nanosponge: A Novel Carrier for Drug Delivery, Drug Delivery Letters 2013; 3 (3) . https://dx.doi.org/10.2174/22103031113039990004
DOI https://dx.doi.org/10.2174/22103031113039990004 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Can Systems Biology Understand Pathway Activation? Gene Expression Signatures as Surrogate Markers for Understanding the Complexity of Pathway Activation
Current Genomics Histone Deacetylase Inhibitors as Potential Therapeutic Agents for the Treatment of Malignant Mesothelioma
Anti-Cancer Agents in Medicinal Chemistry Integrating the Universe of Effector and Regulatory Immune Cell Subsets: An Emerging Role of Protein-Glycan Interactions
Current Immunology Reviews (Discontinued) EMT Blockage Strategies: Targeting Akt Dependent Mechanisms for Breast Cancer Metastatic Behaviour Modulation
Current Gene Therapy An Implantable Drug-delivery System on a Chip
Current Topics in Medicinal Chemistry Tumor Suppression by DNA Base Excision Repair
Mini-Reviews in Medicinal Chemistry Recent Advances of Sulfonylation Reactions in Water
Current Organic Synthesis “SLY AS A FOXO”: New Paths with Forkhead Signaling in the Brain
Current Neurovascular Research Selective Chemokine Receptor-Targeted Depletion of Pathological Cells as A Therapeutic Strategy for Inflammatory, Allergic and Autoimmune Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Light Deficiency Confers Breast Cancer Risk by Endocrine Disorders
Recent Patents on Anti-Cancer Drug Discovery TRICOM Vector Based Cancer Vaccines
Current Pharmaceutical Design Engineered Nanoparticles in Cancer Therapy
Recent Patents on Drug Delivery & Formulation Cachexia and Herbal Medicine: Perspective
Current Pharmaceutical Design Fluorescence Imaging in Cancerology
Current Molecular Imaging (Discontinued) Computational Approaches for Translational Oncology: Concepts and Patents
Recent Patents on Anti-Cancer Drug Discovery Can PPARγ Ligands Be Used in Cancer Therapy?
Current Medicinal Chemistry - Anti-Cancer Agents Biochemistry and Neurobiology of Prosaposin: A Potential Therapeutic Neuro-Effector
Central Nervous System Agents in Medicinal Chemistry Studies on Structures and Functions of Kinases leading to Prostate Cancer and Their Inhibitors
Current Enzyme Inhibition Natural DNA Intercalators as Promising Therapeutics for Cancer and Infectious Diseases
Current Cancer Drug Targets Carotenoids and Modulation of Cancer: Molecular Targets
Current Pharmacogenomics